Document is current
Any future updates will be listed below
-
Authors
Spiegelberg, Andreas
Boraschi, Andrea
Amirah, Ramy
Wolf, Katharina
Shah, Mukesch
Krismer, Laura
Beck, Jürgen
Kurtcuoglu, Vartan
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 6 February 2025
First Online: 6 March 2025
Declarations
:
: The study was approved by the Ethics Committee of the University Hospital Freiburg, Germany (ethics committee decision number 21–1582) and carried out in adherence to the Declaration of Helsinki.
: Written informed consent was obtained from all patients.
: AS is applicant and inventor of the patent application DE102018100697A1 and several dependent international applications. VK is inventor and the University of Zurich applicant of the same patent application. AS is the owner of Cephalotec. AB, RA, KW, MS, LK, and JB declare no conflict of interest.
